WARRENVILLE, Ill., May 13, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced that Chairman and Chief Executive Officer Vince Arnone is scheduled to present and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Investor Conference, taking place on May 21-22, 2025. Presentation Date & Time: May 22, 2 ...

RTX Corp. (RTX) recently revealed that its PhantomStrike radar has completed its inaugural flight test in Ontario, CA. During the test, PhantomStrike effectively tracked multiple airborne targets and delivered high-resolution terrain mapping, demonstrating its advanced capabilities.It is the industry’s first fully air-cooled, fire-control radar, engineered for long-range threat detection, tracking and targeting. Amid the evolving landscape of the global threat environment, such an announcement involving an ...

Core Insights - ClearSign Technologies Corporation has received an engineering order for an additional retrofit burner for a flare from an energy company in California, indicating a growing demand for low emissions solutions [1][2] - This order marks the second burner sold to this customer within the year and the third overall, reinforcing the company's position in advanced combustion technologies [2] - The retrofit burner is intended to be installed in an enclosed flare at a production facility in the San Joaquin Valley, with installation expected in the fourth quarter of 2025 [2] Company Overview - ClearSign Technologies Corporation specializes in designing and developing technologies aimed at decarbonization, operational performance, energy efficiency, emission reduction, and safety [3] - The company's patented technologies, such as ClearSign Core™ and ClearSign Eye™, enhance combustion systems and fuel safety across various industries, including energy, commercial/industrial boiler, chemical, and power [3]

Range Truck Group joins as key Pacific Northwest partner; third Midwest Ziegler Truck Group location addedCINCINNATI, May 13, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced the expansion of its partnership with Ziegler Truck Group, adding two new dealer locations to its national network. Range Truck Group, located in Fife, Washington, joins t ...

Core Insights - Humacyte, Inc. has successfully launched its product Symvess™ for treating extremity vascular trauma, marking a significant milestone for the company [2][3] - The company reported total revenues of $517,000 for the first quarter of 2025, with $147,000 from the initial commercial sales of Symvess and $370,000 from a research collaboration [9][27] - Humacyte completed a public offering that raised $46.7 million in net proceeds, which will help extend its cash runway [6][9] Market Launch and Sales - The commercial launch of Symvess began in late February 2025, with initial shipments to three Level 1 trauma centers [3] - 45 hospitals have initiated the Value Analysis Committee (VAC) approval process for Symvess, with five hospitals already approving its purchase [2][3] - The company anticipates further approvals and sales growth in the upcoming quarters [3] Financial Performance - The first quarter of 2025 saw a revenue increase to $517,000 compared to no revenue in the same period of 2024 [9][27] - Research and development expenses decreased to $15.4 million from $21.3 million year-over-year, attributed to reduced material costs and clinical study expenses [9][27] - General and administrative expenses rose to $8.1 million from $5.3 million, primarily due to the costs associated with the commercial launch of Symvess [9][27] Cost Management and Future Plans - The company implemented cost reduction measures, including workforce reductions and deferring new hires, aiming for estimated savings of approximately $13.8 million in 2025 and up to $38 million in 2026 [6][9] - Humacyte plans to file an Investigational New Drug (IND) application with the FDA for the small-diameter ATEV™ in coronary artery bypass grafting (CABG) later this year [2][8] - The company is on track to submit a supplemental Biologics License Application (BLA) for ATEV in dialysis in 2026, following a major enrollment milestone in its Phase 3 trial [2][8] Corporate Developments - Humacyte was issued a new U.S. patent in January 2025, providing protection for its biomanufacturing platform until 2040 [4] - The company reported a net income of $39.1 million for the first quarter of 2025, a significant improvement from a net loss of $31.9 million in the same period of 2024 [17][27] - As of March 31, 2025, Humacyte had cash, cash equivalents, and restricted cash totaling $113.2 million [17][28]

Core Insights - Coop Pank experienced strong growth in its loan portfolio due to a significant issuance of business and home loans in April 2025 [1] - The bank's loan portfolio quality remains robust despite economic uncertainties, with a new leasing product introduced for used vehicle financing [2] - A deliberate reduction in deposit volume was linked to a successful issuance of covered bonds, providing a stable funding source [3] Financial Performance - The number of clients increased by 1,700 to reach 214,400, while active clients decreased by 100, marking a 12% growth in the customer base year-over-year [5] - Customer deposits decreased by 107 million euros to 1.81 billion euros, with corporate deposits down by 74 million euros and private deposits down by 5 million euros [5] - The loan portfolio grew by 53 million euros to 1.87 billion euros, with business loans increasing by 39 million euros and home loans by 13 million euros [5] - The bank's net profit for April was 1.8 million euros, with a 19% decrease in net profit for the first four months compared to the previous year [5] - Return on equity stood at 10.3% and the cost-income ratio was 53% in April [5]

Financial Data and Key Metrics Changes - Net sales from continuing operations totaled $24.7 million, down from $28 million in Q1 2024, reflecting broader market softness [4] - Adjusted EBITDA from continuing operations improved significantly, swinging from a loss of $2.7 million in the prior year to a positive $843,000 this quarter, marking a $3.5 million turnaround [5][20] - Gross profit nearly doubled to $4.8 million, or 19.3% of sales, compared to $2.3 million, or 8.3% last year, an expansion of over 1,100 basis points [17] Business Line Data and Key Metrics Changes - Tubular Segments generated $6.9 million in revenue, down slightly year over year, but gross margin increased from 12.3% to 24.8%, with adjusted EBITDA rising nearly five times to $1.3 million [6] - Specialty Chemicals segment revenue declined year over year to $17.8 million, but gross profit increased by $2.1 million, rising from $1.6 million to $3.7 million, a 131% improvement, with gross margin expanding from 7.6% to 21% [9] Market Data and Key Metrics Changes - Average daily trading volume increased to approximately 63,000 shares in Q1 2025, a 60% lift compared to Q1 2024, indicating growing market interest [13] Company Strategy and Development Direction - The company is focused on strategic repositioning, actively choosing to exit low-margin business in favor of higher value, more technically demanding opportunities [15][16] - The goal for the Specialty Chemicals segment is to shift from a 75% commodity and 25% blended mix to a 60% and 40% mix by the end of 2025, aiming for a more balanced portfolio [35] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are signs of improvement, demand remains soft, and they are still evaluating options to monetize the value of their assets [28][29] - The company is not ready to provide forward-looking guidance for 2025, as they are still stabilizing their operations [30][31] Other Important Information - The company ended the quarter with $14.3 million in cash and no debt before the divestiture of Bristol assets for $45 million, providing significant flexibility for capital deployment [21][22] - The company repurchased approximately 17,000 shares at an average price of $12.73, reinforcing confidence in intrinsic value and long-term fundamentals [21] Q&A Session Summary Question: Comments on the ASTI business and its attractiveness as a target - Management indicated that while there are additional looks due to tariffs, demand remains incredibly soft, and the market conditions have not materially changed [28] Question: Possibility of selling ASTI in 2025 - Management confirmed they are always evaluating options to monetize the value of all assets [29] Question: Guidance for profitability in chemicals - Management stated it is premature to provide guidance as they are still stabilizing operations [30][31] Question: Growth plans for chemicals by 2026 - Management expects to see some growth in the second half of the year, with a more compelling top line anticipated in 2026 [33] Question: Capacity and CapEx for growth - Management confirmed that growth can be achieved with existing capacity and minimal CapEx, with a run rate of $1 to $3 million per year [36] Question: Stock buyback limitations - Management explained that the buyback was executed within the confines of the existing program, and optionality has increased post-Bristol sale [37] Question: Perception of stock valuation - Management expressed the opinion that the stock remains undervalued at current levels [38]

Select First Quarter 2025 Highlights Revenue rose 29% to $6.4 millionGross margin expanded to 46.4%Operating loss narrowed to $1.0 millionBacklog rose 66% to $10.3 millionCash, cash equivalents and investments of $31.2 million, no long-term debt WARRENVILLE, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported ...

Core Viewpoint - The nuclear power sector is experiencing a surge in stock prices due to potential policy changes aimed at accelerating the construction of new nuclear plants and reactivating older ones, which could lead to increased revenues and reduced costs for companies in this industry [2][3][8]. Group 1: Market Reaction - Shares of nuclear power producers Constellation Energy, Vistra, and Oklo saw significant gains, with Vistra leading at a 6% increase, followed by Constellation at 5.9%, and Oklo at 3.3% [2][4]. - The stock price movements may be influenced by broader investor enthusiasm following the Trump administration's announcement of a temporary lifting of tariffs on China [2]. Group 2: Policy Implications - The Trump administration plans to issue executive orders to expedite the construction of new nuclear power plants and reactivate existing ones, aiming for a "wholesale revision" of federal safety guidelines to reduce regulatory hurdles [3][7]. - The goal is to quadruple nuclear power generating capacity to 400 gigawatts by 2050, indicating substantial growth potential in the sector [6]. Group 3: Financial Outlook - The anticipated reduction in construction costs and increased sales could significantly enhance profits for companies like Constellation, Vistra, and Oklo [7][8]. - Recent nuclear reactors in the U.S. have faced cost overruns and delays, with construction costs being twice the initial estimates and taking seven years longer than planned, primarily due to regulatory challenges [7]. Group 4: Investment Considerations - Despite the positive outlook, the average time to build a nuclear power plant in the U.S. is 11 years, suggesting that any new projects may not be completed for several years, potentially impacting stock performance [9]. - Valuations of these stocks vary, with Vistra trading at 22 times earnings and expected to grow earnings by 21% over the next five years, while Constellation trades at 28 times earnings with lower growth expectations [10]. - Oklo, as a start-up, does not have a P/E ratio and does not pay dividends, making it a riskier investment compared to established companies [11].

Financial Data and Key Metrics Changes - Redwire recorded revenues of $61.4 million, a decrease both sequentially and year-over-year [23] - Adjusted EBITDA improved sequentially from a negative $9.2 million in Q4 2024 to a negative $2.3 million in Q1 2025 [24] - The net loss was $2.9 million, showing a significant sequential improvement of over $60 million [25] - Total liquidity reached $89.2 million, a 39.2% improvement from $64.1 million at the end of the previous year [25] Business Line Data and Key Metrics Changes - Contract awards in Q1 2025 were $56.2 million with a book-to-bill ratio of 0.92x, showing significant improvement [18] - Backlog remained relatively flat at $291.2 million as of March 31, 2025, with 37% or $107.2 million from international operations in Europe [19] - The company saw key wins in the European market, including contracts for the International Birthing and Docking Mechanism and the Arrakis mission study [19] Market Data and Key Metrics Changes - The company noted delays in awards in the U.S. Government market due to transitions in key decision-makers and budget uncertainties [19] - There is an estimated $6 billion of identified opportunities in the pipeline, with approximately $5 billion in proposals submitted during Q1 2025 [20] Company Strategy and Development Direction - Redwire's 2025 growth strategy focuses on five key principles: providing foundational products, delivering multi-domain platforms, exploring lunar and Martian missions, unlocking venture optionality, and executing accretive M&A [4][5] - The company aims to capitalize on increased European independence in space and defense, while also addressing U.S. defense spending pressures [38] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future U.S. National security space and defense budgets despite current delays [20] - The company reaffirmed its combined revenue forecast for 2025 to be in the range of $535 million to $605 million, representing a 52.9% compound annual growth rate from FY 2023 to FY 2025 [28] Other Important Information - Redwire's supply chain is resilient, with a U.S.-based supply chain for domestic customers and a European-based supply chain for international clients, mitigating tariff impacts [14] - The company is actively pursuing multiple opportunities related to the Golden Dome defense initiative [17] Q&A Session Summary Question: Risks associated with Europe's increased independence in Space and Defense - Management acknowledged that Europe is investing more in independent space programs, which could create new opportunities despite potential shifts in U.S.-European partnerships [36][38] Question: Changes in U.S. Government program prioritization - Management noted that the current environment is dynamic, with some programs being deprioritized while others, like Golden Dome, are prioritized [40] Question: Edge Autonomy acquisition and its impact - Management highlighted that drones are becoming a significant part of defense spending, particularly in the U.S. and European markets, and Edge Autonomy will enhance capabilities in this area [46][48] Question: Details on Edge Autonomy's performance and pipeline - Management refrained from disclosing specific Q1 performance metrics for Edge but noted an increase in its backlog to $99.4 million [57] Question: Future deals focus between space and unmanned systems - Management indicated a balanced approach, being opportunistic across both segments while ensuring acquisitions are accretive [90][92]